VAXIGRIP susp inj 2026/2027 ser pré 0.5 ml

7680700510059 CH-70051 J07BB02 08.08.

No images available

Details

GTIN
7680700510059
Pharmacode
-
Product number
7005103
CPT
-
Packaging group
1
Unit
Fertigspritze(n)
Composition
haemagglutininum influenzae A (H1N1) (Virus souche A/Missouri/11/2025 (H1N1)pdm09-like: reassortant virus IVR-278 derived from A/Switzerland/6849/2025) 15 µg, haemagglutininum influenzae A (H3N2) (Virus souche A/Darwin/1454/2025 (H3N2)-like: reassortant virus SAN-049A derived from A/Michigan/105/2025) 15 µg, haemagglutininum influenzae B (Virus souche B/Tokyo/EIS13-175/2025-like: B/Tokyo/EIS13-175/2025, wilde type (Victoria lineage)) 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.72 mg, kalium 0.08 mg, residui: formaldehydum, octoxinolum-9, ovalbuminum, neomycinum.

Articles (1)

Vaxigrip, suspension injectable
Injektionssuspension
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
18/07/2026
Professional SmPC
Français
18/07/2026
Professional SmPC
Italien
18/07/2026

Detailed composition

Substance Quantity Type Category
haemagglutininum influenzae A (H1N1)
15.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae A (H3N2)
15.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae B
15.0 UG Substance Wirkstoff (Principe actif)
natrii chloridum
- Substance HNIDK
kalii chloridum
- Substance HNIDK
dinatrii phosphas dihydricus
- Substance HNIDK
kalii dihydrogenophosphas
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
1.72 MG Substance HBESI
kalium
0.08 MG Substance HBESI
formaldehydum
- Substance RESI
octoxinolum-9
- Substance RESI
ovalbuminum
- Substance RESI
neomycinum
- Substance RESI

Reimbursement information

Public price
CHF 26.85
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2026

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
70051
Drug name
Vaxigrip, suspension injectable
Galenic form
SUPAS
ATC Code
J07BB02
Authorization status
Z
Dispensation category
B
First authorization
06/05/2025
Authorization expiration date
05/05/2030
IT number
08.08.
Domain
Human medicine

Packaging details

Description (FR)
VAXIGRIP susp inj 2026/2027 ser pré 0.5 ml
Description (DE)
VAXIGRIP Inj Susp 2026/2027 Fertspr 0.5 ml
Market launch
07/09/2026
Narcotic (BTM)
No

Other packaging sizes

VAXIGRIP susp inj 15 µg 1 pce
1 FESP
GTIN: 7680700510035
View
VAXIGRIP susp inj 2026/2027 10 ser pré 0.5 ml
10 FESP
GTIN: 7680700510066
View
Buy us a coffee Explore the data